AVIEW LCS vs DeepTek CXR Analyzer
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your primary need is a comprehensive, AI-powered solution for detailed lung cancer screening and multi-modal cardiopulmonary assessment using low-dose CT scans. This tool is ideal for clinics and hospitals requiring advanced nodule quantification, Lung-RADS classification, and integrated analysis of COPD and coronary artery calcification for a holistic patient evaluation and follow-up.
View AVIEW LCS →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you need an efficient AI-powered CADe solution to assist with the initial interpretation and workflow automation of chest X-rays. This tool is best suited for high-volume environments looking to reduce radiologist workload and improve turnaround times by automatically detecting and highlighting a wide range of lung, pleural, and cardiac pathologies on various X-ray modalities.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Subscription or one-off payment | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly highlights features like 'Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'' and 'Generates secondary capture DICOM with AI output for easy interpretation'. These features directly streamline radiologist workflow and enhance ease of interpretation, offering a clear advantage in daily usability. AVIEW LCS also offers good integration and reporting, but DeepTek's features are more specific to workflow optimization.
Clinical Value
AVIEW LCSAVIEW LCS provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, offering comprehensive quantitative measurements and automated follow-up comparisons. This multi-disease, multi-organ analysis from a single scan provides a deeper and broader clinical assessment compared to DeepTek CXR Analyzer's CADe for 28 findings on X-rays.
Pricing & Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers more transparency in its pricing model by explicitly stating 'Pay-per-use'. This provides potential customers with a clearer understanding of cost structures and allows for more flexible cost management based on usage. AVIEW LCS only states 'contact for pricing', offering no public details on its pricing model.
Enterprise Readiness
AVIEW LCSBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating foundational enterprise readiness. However, AVIEW LCS offers a wider array of deployment options including 'Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)', providing greater flexibility to integrate into diverse enterprise IT infrastructures and security policies.
Innovation
AVIEW LCSAVIEW LCS demonstrates higher innovation by providing integrated, fully automatic analysis of three major thoracic diseases (lung cancer, COPD, and coronary artery calcification) from a single low-dose CT scan. Its advanced quantitative measurements, 3D segmentation, and automated nodule comparison for follow-up scans represent a more comprehensive and integrated diagnostic approach.
Support & Docs
DeepTek CXR AnalyzerDeepTek CXR Analyzer's company, DeepTek, explicitly provides a dedicated customer support email and phone, along with a 'Resources Hub' that includes a 'Knowledge Base', white papers, blogs, and case studies. This indicates a more comprehensive and publicly accessible suite of support and documentation compared to Coreline Soft, which primarily lists contact information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | DeepTek CXR Analyzer |
|---|---|---|
| Name | AVIEW LCS | DeepTek CXR Analyzer |
| Company | Coreline Soft Co. | DeepTek Medical Imaging Pvt |
| Description | AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows. | FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. |
| Primary Modality | CT scans | Chest X-rays |
| Key Features (Selection) | Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass), Automated comparison of nodules in follow-up CT scans, Comprehensive, automated report generation, Integration with PACS/RIS and third-party platforms | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware, Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs), Seamless DICOM-based PACS integration (on-premise or cloud), Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive', Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x, Generates secondary capture DICOM with AI output for easy interpretation, Compatible with various X-ray modalities (hospital, mobile, portable, handheld) |
| Specialties | Cardiology, Oncology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and DeepTek CXR Analyzer.